{"entity":{"id":"nct03271918","kind":"trial","name":"Cabergoline in Nonfunctioning Pituitary Adenomas","aka":[],"tldr":"A phase 3 trial of Cabergoline in Pituitary tumours, run by University of Sao Paulo General Hospital, completed.","summary":"Cabergoline in Nonfunctioning Pituitary Adenomas is a phase 3 interventional study registered as NCT03271918 by University of Sao Paulo General Hospital, with 140 participants recorded, started 2015-02-01 and reaching its primary completion in 2017-02-01. Interventions recorded: Cabergoline. Conditions recorded: Pituitary Adenoma, Nonfunctioning Pituitary Adenoma.\n\nLinked to the drug Cabergoline because the registry names it among its interventions and Pituitary tumours among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT03271918","url":"https://clinicaltrials.gov/study/NCT03271918"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["pituitary-tumours"],"sections":[],"technologies":[],"targets":[],"drugs":["cabergoline"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03271918","phase":"3","setting":"Dopamine Agonist Cabergoline in Residual Clinically Nonfunctioning Pituitary Adenoma After Transphenoidal Surgery: A Single Center, Open Label and Randomized Clinical Trial","sponsor":"University of Sao Paulo General Hospital","enrolled":140,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03271918/","neighbours":{"cancer":[{"id":"pituitary-tumours","kind":"cancer","name":"Pituitary tumours (pituitary neuroendocrine tumours) and pituitary carcinoma","route":"/cancers/pituitary-tumours/"}],"drug":[{"id":"cabergoline","kind":"drug","name":"Cabergoline","route":"/drugs/cabergoline/"}]}}